22Mar
HHS Declares Liability Immunity for Certain COVID-19 “Countermeasures”; Response Act Expands Protections for Mask Makers
Earlier this week, we discussed current trends and future implications of COVID-19 on businesses operating in the products arena, noting the most direct impact so far on the pharmaceutical and medical device spaces. Recognizing the potential...
By:
Butler Snow LLP
Related
The SEC has issued its final Regulation Best Interest (Reg BI), Form CRS Regulation, RIA Interpretat...
Read More >
ICE is now conducting worksite inspections for STEM OPT employers. ICE’s stated purpose for conduct...
Read More >
On November 15, the Department of Health and Human Services, the Department of Labor, and the Depart...
Read More >
Your organization spends significant capital crafting your corporate brand and reputation to appeal ...
Read More >
Italian Restaurant Unlawfully Fired Server Because of Pregnancy and Childbirth, Federal Agency Charg...
Read More >
On January 3, 2020, Axon Enterprises Inc. filed a complaint against the Federal Trade Commission in ...
Read More >